Cargando…

Corrigendum to ‘Understanding p53 functions through p53 antibodies’

Detalles Bibliográficos
Autores principales:	Sabapathy, Kanaga, Lane, David P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934150/ https://www.ncbi.nlm.nih.gov/pubmed/31881082 http://dx.doi.org/10.1093/jmcb/mjz110

Ejemplares similares

Understanding p53 functions through p53 antibodies
por: Sabapathy, Kanaga, et al.
Publicado: (2019)

Corrigendum: The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
por: Sabapathy, Kanaga
Publicado: (2021)

The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
por: Sabapathy, Kanaga
Publicado: (2015)

Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53
por: Vikhanskaya, Faina, et al.
Publicado: (2007)

Corrigendum to ‘p53 balances between tissue hierarchy and anarchy’
por: Koifman, Gabriela, et al.
Publicado: (2019)

FUCA1 is induced by wild-type p53 and expressed at different levels in thyroid cancers depending on p53 status
Publicado: (2017)

Cancer Cells Shuttle Extracellular Vesicles Containing Oncogenic Mutant p53 Proteins to the Tumor Microenvironment
por: Bhatta, Bibek, et al.
Publicado: (2021)

Overexpression of RNF126 Promotes the Development of Colorectal Cancer via Enhancing p53 Ubiquitination and Degradation [Corrigendum]
Publicado: (2021)

p53-Related Transcription Targets of TAp73 in Cancer Cells—Bona Fide or Distorted Reality?
por: Wang, Chao, et al.
Publicado: (2020)

Corrigendum to “Prognostic Effect of Long Noncoding RNA NEAT1 Expression Depends on p53 Mutation Status in Cancer”
por: Idogawa, Masashi, et al.
Publicado: (2019)

20(S)-Ginsenoside Rg3 Promotes Senescence And Apoptosis In Gallbladder Cancer Cells Via The P53 Pathway [Corrigendum]
Publicado: (2019)

Cancer therapeutic targeting using mutant–p53-specific siRNAs
por: Ubby, Ifeoma, et al.
Publicado: (2019)

Corrigendum to: SOX6 suppresses the development of lung adenocarcinoma by regulating expression of p53, p21(CIPI), cyclin D1 and β‐catenin
Publicado: (2020)

Corrigendum to article “Quantitative proteomics reveals that long non-coding RNA MALAT1 interacts with DBC1 to regulate p53 acetylation’’
por: Chen, Ruibing, et al.
Publicado: (2021)

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer
por: Sonego, Maura, et al.
Publicado: (2014)

Mutant p53 targeting by the low molecular weight compound STIMA‐1
por: Zache, Nicole, et al.
Publicado: (2017)

Corrigendum to “Ethanol Extract from Ampelopsis sinica Root Exerts Anti-Hepatitis B Virus Activity via Inhibition of p53 Pathway In Vitro”
por: Pang, Ran, et al.
Publicado: (2015)

Corrigendum to “mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19” [Gene Rep. 20 (2020) 100765]
por: Ramaiah, Mekala Janaki
Publicado: (2021)

Methylation-regulated ZNF545 inhibits growth of the p53-mutant KYSE150 cell line by inducing p21 and Bax
por: Fan, Yu, et al.
Publicado: (2021)

Corrigendum to “Feline mammary carcinoma stem cells are tumorigenic, radioresistant, chemoresistant and defective in activation of the ATM/p53 DNA damage pathway” [The Veterinary Journal 196 (2013) 414–423]
por: Pang, L.Y., et al.
Publicado: (2021)

Characterization of Novel and Uncharacterized p53 SNPs in the Chinese Population – Intron 2 SNP Co-Segregates with the Common Codon 72 Polymorphism
por: Phang, Beng Hooi, et al.
Publicado: (2011)

MUTYH, an adenine DNA glycosylase, mediates p53 tumor suppression via PARP-dependent cell death
por: Oka, S, et al.
Publicado: (2015)

Comparative Assessment of the Apoptotic Potential of Silver Nanoparticles Synthesized by Bacillus Tequilensis and Calocybe Indica in MDA-MB-231 Human Breast Cancer Cells: Targeting p53 for Anticancer Therapy [Corrigendum]
Publicado: (2022)

Corrigendum: WCoP Abstracts
Publicado: (2021)

Corrigendum to “Cellular redox imbalance on the crossroad between mitochondrial dysfunction, senescence, and proliferation” [Redox Biol. 53 (2022) 102337]
por: Bakalova, Rumiana, et al.
Publicado: (2022)

p53: out of Africa
por: Lane, David
Publicado: (2016)

Updates on p53: modulation of p53 degradation as a therapeutic approach
por: Dey, A, et al.
Publicado: (2008)

Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL
por: Le Pen, J, et al.
Publicado: (2017)

Corrigendum to: 2022 WCoP Abstracts
Publicado: (2022)

p73: a Positive or Negative Regulator of Angiogenesis, or Both?
por: Sabapathy, Kanaga
Publicado: (2016)

D133P53, directly transactivated by p53, prevents p53-mediated apoptosis without inhibiting p53-mediated cell cycle arrest
por: Aoubala, M, et al.
Publicado: (2010)

Corrigendum to “DNA methylation markers for oral pre-cancer progression: A critical review” [Oral Oncology 53 (2015) 1–9]
por: Shridhar, Krithiga, et al.
Publicado: (2016)

Iron Metabolism Regulates p53 Signaling through Direct Heme-p53 Interaction and Modulation of p53 Localization, Stability, and Function
por: Shen, Jia, et al.
Publicado: (2014)

Corrigendum to ‘single-cell transcriptomics of blood reveals a natural killer cell subset depletion in tuberculosis’ [EBioMedicine 53 (2020) 102686]
por: Cai, Yi, et al.
Publicado: (2022)

53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression – CORRIGENDUM
por: Rothschild, Harriet T, et al.
Publicado: (2023)

Serum p53 Antibody Is Not Associated with p53 Immunoreactivity in Patients with Pancreatobiliary Cancers
por: Umeda, Junko, et al.
Publicado: (2013)

Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness
por: Olivos, David J., et al.
Publicado: (2016)

Corrigendum to “Nitric oxide biosensor uncovers diminished ferrous iron-dependency of cultured cells adapted to physiological oxygen levels” [Redox Biol. 53 (2022) 102319]
por: Sevimli, Gulsah, et al.
Publicado: (2022)

Corrigendum to “Sensitization of Cancer Cells through Reduction of Total Akt and Downregulation of Salinomycin-Induced pAkt, pGSk3β, pTSC2, and p4EBP1 by Cotreatment with MK-2206”
por: Choi, Ae-Ran, et al.
Publicado: (2015)

Progress and challenges in understanding the regulation and function of p53 dynamics
por: Yang, Zhilin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ng550s6fmqbjkkaan41465frko